Phenotypical change of tumor-associated macrophages in metastatic lesions of clear cell renal cell carcinoma

被引:0
|
作者
Takanobu Motoshima
Yuji Miura
Nanako Wakigami
Natsuki Kusada
Toshimi Takano
Naoko Inoshita
Toshikazu Okaneya
Yutaka Sugiyama
Tomomi Kamba
Motohiro Takeya
Yoshihiro Komohara
机构
[1] Kumamoto University,Department of Cell Pathology, Graduate School of Medical Sciences
[2] Kumamoto University,Department of Urology, Graduate School of Medical Sciences
[3] Toranomon Hospital,Department of Medical Oncology
[4] Toranomon Hospital,Department of Pathology
[5] Toranomon Hospital,Department of Urology
来源
Medical Molecular Morphology | 2018年 / 51卷
关键词
TAM; CD163; CD204; Iba1; Metastatic;
D O I
暂无
中图分类号
学科分类号
摘要
Macrophages are the main immune cells of the tumor microenvironment in clear cell renal cell carcinoma (ccRCC). A high density of CD163+ or CD204+ tumor-associated macrophages (TAMs), rather than the density of total TAMs, is known to be linked to poor clinical outcome. In the present study, we investigated the phenotypical differences between the paired primary and metastatic lesions in ccRCC cases. Using immunostaining, the densities of CD163+ and CD204+ TAMs in metastatic lesions were found to be significantly lower compared to primary lesions, although the total number of TAMs was increased in metastatic lesions. Since CD163 and CD204 are considered to be the markers of an M2/protumor phenotype in macrophages, TAMs in metastatic lesions are suggested to have a greater M1/inflammatory function compared with those from primary lesions. These findings give new insights in regard to the immunological status of metastatic lesions of ccRCC.
引用
收藏
页码:57 / 63
页数:6
相关论文
共 50 条
  • [41] Targeting tumor-associated macrophages in head and neck squamous cell carcinoma
    Li, Bolei
    Ren, Min
    Zhou, Xuedong
    Han, Qi
    Cheng, Lei
    ORAL ONCOLOGY, 2020, 106
  • [42] Intraventricular metastatic clear cell renal carcinoma
    Sava, I.
    Sava, Anca
    Sapte, Elena
    Mihailov, Claudia
    Dumitrescu, Gabriela
    Poeata, I.
    Sava, Florina
    Haba, Danisia
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2013, 54 (02): : 447 - 450
  • [43] Metastatic periampullary clear cell renal carcinoma
    Mousa, Omar
    Raimondo, Massimo
    GASTROINTESTINAL ENDOSCOPY, 2016, 83 (05) : 1041 - 1042
  • [44] Cabozantinib for the Management of Metastatic Clear Cell Renal Cell Carcinoma
    Del Vecchio, Sharon J.
    Ellis, Robert J.
    JOURNAL OF KIDNEY CANCER AND VHL, 2018, 5 (04): : 1 - 5
  • [45] Integration of intratumoral RASSF10 expression and tumor-associated macrophages into the established clinical indicators better predicts the prognosis of clear cell renal cell carcinoma patients
    Wang, Chao
    Hong, Tianyu
    Wang, Yuning
    Gan, Sishun
    Wang, Qifeng
    Li, Jian
    Zuo, Li
    Cui, Xingang
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [46] Pharmacotherapy for treating metastatic clear cell renal cell carcinoma
    Porta, Camillo
    Chiellino, Silvia
    Ferrari, Alessandra
    Mariucci, Sara
    Liguigli, Wanda
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (02) : 205 - 216
  • [47] Detection of circulating tumor DNA in patients with metastatic clear cell renal cell carcinoma.
    Nappi, Lucia
    Bacon, Jack
    Annala, Matti
    Soleimani, Maryam
    Lavoie, Jean-Michel
    Chi, Kim N.
    Wyatt, Alexander William
    Kollmannsberger, Christian K.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] Metastatic clear cell renal cell carcinoma to the adrenal gland without an identifiable primary tumor
    Johnson, Matthew T.
    Bahnson, Robert R.
    Zynger, Debra L.
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 (01) : 92 - 93
  • [49] Low Fluorodeoxyglucose Uptake in the Metastatic Lung Tumor From Clear Cell Renal Cell Carcinoma
    Yoshida, Mami
    Oura, Shoji
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [50] Role of circulating tumor cells in patients with metastatic clear-cell renal cell carcinoma
    Nayak, Brusabhanu
    Panaiyadiyan, Sridhar
    Singh, Prabhjot
    Karmakar, Subhradip
    Kaushal, Seema
    Seth, Amlesh
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (02) : 135.e9 - 135.e15